{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Catherine+McKinnell&AnsweringBody.=Department+of+Health", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Catherine+McKinnell&AnsweringBody.=Department+of+Health", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Catherine+McKinnell&AnsweringBody.=Department+of+Health&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Catherine+McKinnell&_page=0&AnsweringBody.=Department+of+Health", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Catherine+McKinnell&AnsweringBody.=Department+of+Health", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Catherine+McKinnell&AnsweringBody.=Department+of+Health", "items" : [{"_about" : "http://data.parliament.uk/resources/798570", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/798570/answer", "answerText" : {"_value" : "
The Department funds research via the National Institute for Health Research (NIHR). Research funded by the NIHR generates a wide range of intellectual property (IP) assets ranging from patents to clinical data. In a knowledge driven economy, effective management of IP is essential to help realise the expected benefits of publicly funded research. In line with other health research funders, IP is produced and managed by diverse third party research organisations including on occasion private companies.<\/p>
<\/p>
To manage any inherent risks, including those specific to the transfer of rights to private companies, the NIHR has effective commissioning, due diligence, monitoring, analysis and approval mechanisms to ensure that funding recipients are maximising the impact of NIHR-funded IP and that benefits accrue to taxpayers. Furthermore, the NIHR has established an IP Unit to oversee the effective operation and risk management of these activities, and the IP generated across the spectrum of NIHR funding.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-12-06", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-12-06T17:15:17.387Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-12-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment his Department has made of the potential risks of transferring intellectual property rights of publicly-funded health research to private companies; and what steps his Department is taking to manage those potential risks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4125", "label" : {"_value" : "Biography information for Catherine McKinnell"} } , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne North"} , "tablingMemberPrinted" : [{"_value" : "Catherine McKinnell"} ], "uin" : "116964"} , {"_about" : "http://data.parliament.uk/resources/757046", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/757046/answer", "answerText" : {"_value" : "
The Government strongly values the crucial role of the children's hospice sector in providing excellent end-of-life care across the country. Clinical commissioning groups (CCGs) are responsible for determining the level of National Health Service-funded hospice care locally and they should ensure that the services they commission meet the needs of their local population.<\/p>
In addition to NHS funding for locally commissioned services, children\u2019s hospices received £11 million in 2017/18 through the Children\u2019s Hospice grant, which is awarded annually and administered centrally by NHS England. NHS England engaged with children\u2019s hospices through the children\u2019s charity Together for Short Lives prior to a consultation on the allocation method for the 2017/18 grant.<\/p>
<\/p>
In April 2017 NHS England made available a new children\u2019s specialist palliative care currency for local areas. CCGs may choose to use this when working with providers, such as hospices, to establish a framework for understanding specialist palliative care service need locally, and providers may find the currency model useful as a tool for demonstrating the increasing complexity of care provision and to make the case for local investment.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-09-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-09-07T09:59:15.293Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-09-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hospices: Finance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what plans he has to increase the parity of funding of children's hospices and adult hospices.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4125", "label" : {"_value" : "Biography information for Catherine McKinnell"} } , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne North"} , "tablingMemberPrinted" : [{"_value" : "Catherine McKinnell"} ], "uin" : "8162"} , {"_about" : "http://data.parliament.uk/resources/753480", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/753480/answer", "answerText" : {"_value" : "
The Implementation Plan for the 2020 Challenge on Dementia 2020 highlights our continuing global leadership role on dementia, stressing the importance of working closely with our international partners, including the World Health Organization, the Organisation for Economic Cooperation and Development, the World Dementia Council and countries within the G7, European Union and beyond.<\/p>
<\/p>
At a summit in December 2013, the then G8 countries agreed a new international approach to dementia research to realise the ambition to identify a cure or disease modifying therapy by 2025 and to increase collectively and significantly their funding for dementia research.<\/p>
<\/p>
The Government has doubled research spending on dementia, with a commitment to maintain this level of spending at £60 million a year to 2020, with an ambition for overall spending on research from all sectors to double by 2025. Much of this investment is in research to better understand the nature of dementia, to inform development of future treatments and ways to prevent the onset of the condition.<\/p>
<\/p>
The Government remains committed to tackling dementia domestically and internationally. We will ensure that the 2020 Challenge on Dementia is delivered in full so that, by 2020, England is the best place in the world for dementia care and support, as well as for undertaking research into dementia and other neurodegenerative diseases.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-09-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-09-05T14:35:23.977Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Dementia: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to ensure patients with dementia continue to receive timely access to new treatments after Britain leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4125", "label" : {"_value" : "Biography information for Catherine McKinnell"} } , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne North"} , "tablingMemberPrinted" : [{"_value" : "Catherine McKinnell"} ], "uin" : "5685"} , {"_about" : "http://data.parliament.uk/resources/753482", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/753482/answer", "answerText" : {"_value" : "
The Department funds research on health and social care through the National Institute for Health Research (NIHR). The NIHR does not usually ring-fence funds for particular topics. Awards are made in open competition on the basis of importance of topics to patients and heath and care services, value for money, and scientific quality judged through peer review. The amount of NIHR funding in topic areas depends on the volume and quality of scientific activity. This includes research on dementia care, and applied biomedical research in dementia. In 2014/15 (the most recent year for which a breakdown is available) total Department funding for dementia related research was £31.5 million. Of this, an estimated £12.3 million was for research on dementia services and care.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-09-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-09-05T13:26:07.12Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Dementia: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to ensure greater parity between research in dementia care and bio-medical research on dementia.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4125", "label" : {"_value" : "Biography information for Catherine McKinnell"} } , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne North"} , "tablingMemberPrinted" : [{"_value" : "Catherine McKinnell"} ], "uin" : "5686"} , {"_about" : "http://data.parliament.uk/resources/732684", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/732684/answer", "answerText" : {"_value" : "
On 5 July 2016 we published Our Commitment to you for end of life care, which set out what everyone should expect from their care at the end of life and the actions we are taking to make high quality and personalisation in care a reality for everyone, both adults and children. This Commitment includes measures to enable personalisation, measures to improve care quality and education and training in end of life care and measures to encourage the spread of innovative models of care. This includes enabling greater use of advance care planning and electronic care records to record people\u2019s choices and preferences, and building services around people\u2019s needs and preferences. Our Commitment to you for end of life care is available at the following link:<\/p>